Dr. Ankur Bahl

Dr. Ankur Bahl

MBBS, MD, DM

Medical Oncologist

Senior Director-Medical Oncology

Fortis Memorial Research Institute

21 Years of Experience

Reg. No.:1854, Delhi Medical Council

About Dr. Ankur Bahl

  • Dr. Ankur Bahl is a distinguished Medical Oncologist with over 21 years of extensive experience in the field.
  • He completed his MBBS from Maulana Azad Medical College, Delhi, followed by an MD in Medicine.
  • He pursued his DM in Medical Oncology from the All India Institute of Medical Sciences (AIIMS), New Delhi.
  • He has completed a course on Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance at the University of Oxford, UK.
  • Dr. Bahl specializes in immunotherapy, targeted therapy combined with chemotherapy, hormonal therapy, and comprehensive supportive and palliative care.
  • He has led landmark studies, including the largest real-world Indian data on Cetuximab in Head & Neck cancer and advancements in Acute Myeloid Leukemia treatment.
  • He has significantly contributed to epidemiological research, particularly in analyzing trends of Human Papillomavirus (HPV) prevalence in the Indian population.
  • Dr. Bahl was awarded the Gold Medal for Best Outgoing Postgraduate Student in the Department of Medicine.
  • He is a member of the American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO), and Indian Society of Medical and Paediatric Oncology (ISMPO).
Book a Consultation Call
Education
  • MBBS, Moulana Azad Medical College, New Delhi, 2003
  • MD (Internal Medicine), G B Pant Hospital / Moulana Azad Medical College, New Delhi, 2007
  • DM (Medical Oncology), All India Institute of Medical Sciences, New Delhi, 2012
Past Experience
  • Director (Medical Oncology & Haematology), Max Superspecialty Hospital, Saket, New Delhi, 2021
  • Senior Resident (Medicine), Rajiv Gandhi Cancer Institute and Research Center, Delhi
  • Senior Resident (Medicine), Maulana Azad Medical College, New Delhi, 2009
Awards
  • Gold Medal for Best Outgoing Postgraduate Student in the Department of Medicine.
Dr. Ankur Bahl’s Expertise
  • Immunotherapy
  • Targeted therapies in combination with chemotherapy
  • Hormonal therapy
  • Supportive and palliative care
  • Chemotherapy
  • Lymphoma
  • Breast Cancer
  • Head & Neck cancer
  • Acute Myeloid Leukemia treatment
Associations/Membership
  • American Society of Clinical Oncology (ASCO)
  • European Society of Medical Oncology (ESMO)
  • Indian Society of Medical and Paediatric Oncology (ISMPO)
Research Paper Published
  • Muto, Manabu & Sunakawa, Yu & Sandhir, Nippun & Liang, Yi & Dawood, Sara & Rohatgi, Nitesh & Bahl, Ankur & Olsen, Steve. (2025). Real-World Genomic Landscape of Gastrointestinal Cancers in Asia and the Middle East Using Comprehensive Circulating Tumor DNA Next-Generation Sequencing. Oncology research and treatment. 1-33. 10.1159/000545560.
  • Bahl, Ankur & Bansal, Nupur & Shrivastav, Gunjan. (2025). Abiraterone acetate–induced delayed rhabdomyolysis: A rare presentation in metastatic carcinoma prostate. Indian Journal of Cancer. 61. 613-616. 10.4103/ijc.IJC_6_21.
  • Parikh, Purvish & Bahl, Ankur & Sharma, Gopal & Pramanik, Raja & Wadhwa, Jyoti & Bajpai, Peush & Jandyal, Sunny & Dubey, A & Sarin, Aditya & Dadhich, Subash & Saklani, Avanish & Kumar, Ashok & Chandra, Abhijit & Rawat, Saumitra & Selvasekar, C. & Aggarwal, Shyam. (2024). Management of Metastatic Colorectal Cancer (mCRC): Real-World Recommendations. South Asian Journal of Cancer. 13. 10.1055/s-0044-1791689.
  • Muddu, Vamshi & Shah, Anjali & John, Anupa & Raj, Abhishek & Bahl, Ankur & Rajappa, Senthil & Raja, Thirumalairaj & Ghosh, Joydeep & Lavingia, Viraj & Vora, Amish & Bhargava, Prabhat & Ramaswamy, Anant & Khan, Arif & Sharma, Atul & Trikha, Mehak & Dhanawat, Aditya & Bonda, Avinash & Siripurapu, Indraja & Mahajan, Manoj & Ostwal, Vikas. (2024). Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From India. JCO global oncology. 10. e2400216. 10.1200/GO.24.00216.
  • Ramshankar, Vijayalakshmi & G, A. & Radhakrishnan, Venkatraman & Krishnamurthy, Arvind & Mukherhee, T.A. & Arya, D. & Gowda, C. & Bahl, A. & Gore, A. & Bipte, S. & Deshmukh, C.D. & Hingmire, S. & Raizada, N. & Tandon, N. & Muddu, V. & Zaveri, S. & Agarwala, V. & Choudhary, N. & Kd, S. & Rautan, A.. (2024). 19P Molecular subtyping and prediction of risk of recurrence for early stage receptor positive breast cancer for using Nanostring nCounter: First study from India. Annals of Oncology. 35. S1411. 10.1016/j.annonc.2024.10.039.
  • Rohatgi, Nitesh & Bahl, A. & Yadav, N. & Bharat, R. & Joshi, N. & Aggarwal, A.. (2024). 512P Genomic alterations associated with high Tumor Mutation Burden (TMB-H) status in advanced solid tumors: A single tertiary care oncology center experience from India. Annals of Oncology. 35. S1590-S1591. 10.1016/j.annonc.2024.10.537.
  • Bahl, A. & Rohatgi, Nitesh & Yadav, N. & Karanth, S. & Bharat, R. & Joshi, N. & Aggarwal, A.. (2024). 501P Comparison between tissue and ctDNA for detecting tumor mutation burden (TMB) across solid tumors: A single centre study from India. Annals of Oncology. 35. S1587. 10.1016/j.annonc.2024.10.526.
  • Rohatgi, Nitesh & Tsai, C-M & Bahl, A. & Rauthan, Amit & Agarwal, A. & Dawood, Sara & Alakasheh, M. & Kaur, A. & Sandhir, N. & Olsen, S.. (2024). 521P Real-world performance of a comprehensive next-generation sequencing (NGS) assay for solid tumor patients in Asia and the Middle East (AME). Annals of Oncology. 35. S1593. 10.1016/j.annonc.2024.10.546.
  • Rohatgi, Nitesh & Karanth, S. & Aggarwal, A. & Bharat, R. & Joshi, N. & Bahl, A. & Jain, S.S.. (2024). 481MO Next-generation sequencing (NGS) of paired tumor tissue and blood samples from patients with advanced solid cancers: A complementary approach. Annals of Oncology. 35. S1581. 10.1016/j.annonc.2024.10.506.
  • Rohatgi, Nitesh & Rauthan, Amit & Limaye, S. & Patil, S. & Sirohi, B. & Julka, P.K. & Chugh, Bhuvan & Dhar, A. & Bharat, R. & Jain, S.S. & Joshi, N. & Bahl, A.. (2024). 44P Genomic mutational profile of breast cancer patients from India through comprehensive next-generation sequencing analysis of circulating tumor DNA. Annals of Oncology. 35. S1421. 10.1016/j.annonc.2024.10.066.
  • Lavingia, V. & Rohatgi, Nitesh & Bahl, A. & Alakasheh, M. & Huang, T-W & Ke, T.W. & Dawood, Sara & Sandhir, N. & Olsen, S.. (2024). 504P Real-world prevalence of homologous recombination repair (HRR) gene mutations in advanced breast (ABC) and selected gastrointestinal cancers (GIC) using comprehensive next-generation sequencing (NGS) assays in Asia and the Middle East (AME). Annals of Oncology. 35. S1588. 10.1016/j.annonc.2024.10.529.
  • Parikh, Purvish & Vora, Amish & Yadav, Rajan & Kapoor, Akhil & Sahoo, Tarini & Rajappa, Senthil & K, Govind Babu & Krishna, M. & Biswas, Ghanashyam & Bahl, Ankur & Ghadyalpatil, Nikhil & Raja, Thirumalairaj & Bajpai, Jyoti & Akhade, Amol & Singh, Randeep & Aggarwal, Shyam & Basade, Maheboob & Advani, S.H.. (2024). Consensus Guidelines for the Use of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in the Management of Hormone Receptor Positive (HR+ve), Her2−ve Early Breast Cancer (EBC). South Asian Journal of Cancer. 14. 10.1055/s-0044-1791768.
  • Shrivastav, Gunjan & Batra, Sandeep & Rohatgi, Nitesh & Gupta, Alok & Siddiqui, Hiba & Arya, Devavrat & Bahl, Ankur & Chaturvedi, Harit. (2024). The clinicopathological profile and treatment outcomes of stage IV lung cancer patients treated at a tertiary cancer center in India. International Journal of Research in Medical Sciences. 12. 4091-4099. 10.18203/2320-6012.ijrms20243355.
  • Bahl, A. & Bharat, R. & Jain, S.S. & Joshi, N. & Rohatgi, Nitesh. (2024). 419P Prevalence of gene rearrangement on ctDNA NGS and its targetability in patients with advanced breast cancer. Annals of Oncology. 35. S396. 10.1016/j.annonc.2024.08.367.
  • Rohatgi, Nitesh & Limaye, Sewanti & Vaid, Ashok & Bahl, Ankur & Choudhary, R & Kulkarni, Shriniwas & Vijayakumar, Rajeev & Reddy, Vijay & Agarwal, Amit & Sandhir, Nippun & Joshi, Nisarg & Datta, Vineet & Patil, Darshana & Datar, Rajan & Crook, Tim & Cristofanilli, Massimo. (2024). Molecular profiling in ABC: Is complementary testing with tissue and plasma necessary and clinically relevant?. Journal of Clinical Oncology. 42. e12566-e12566. 10.1200/JCO.2024.42.16_suppl.e12566.
  • Rohatgi, Nitesh & Sharma, Kunal & Garg, Nidhi & Kembhavi, Priyanka & Karanth, Suman & Pais, Anurita & Manudhane, Roopali & Bahl, Ankur. (2024). HER2/neu in head and neck cancers: A worthy target or not?. Journal of Clinical Oncology. 42. e18022-e18022. 10.1200/JCO.2024.42.16_suppl.e18022.
  • Rohatgi, Nitesh & Agarwal, A. & Bahl, A. & Tsai, C-M & Sandhir, N. & Olsen, S.. (2023). 427P Real-world performance of a comprehensive next-generation sequencing (NGS) panel for patients (pts) with solid tumors from Asia and the Middle East (AME). Annals of Oncology. 34. S1630. 10.1016/j.annonc.2023.10.712.
  • Rohatgi, Nitesh & Agarwal, A. & Maniar, Vashishth & Patil, S. & Bahl, A. & Advani, S. & Julka, P.K. & Limaye, S. & Kakroo, A. & Kumar, A. & Javle, M.. (2023). 117P Genomic landscape of biliary tract cancers from India show distinct geographic variation. Annals of Oncology. 34. S226. 10.1016/j.annonc.2023.09.1410.
  • Kumar, Ashish & Acharya, Subrat & Singh, Shivaram Prasad & Duseja, Ajay & Madan, Kaushal & Shukla, Akash & Arora, Anil & Anand, Anil & Bahl, Ankur & Soin, Arvinder & Sirohi, Bhawna & Dutta, Debnarayan & Jothimani, Dinesh & Panda, Dipanjan & Saini, Gagan & Varghese, Joy & Kumar, Karan & Premkumar, Madhumita & Panigrahi, Manas & Chawla, Yogesh. (2023). 2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations. Journal of Clinical and Experimental Hepatology. 14. 10.1016/j.jceh.2023.08.005.
  • Rohatgi, Nitesh & Batra, Ullas & Prabhash, Kumar & Limited, Datar & Datta, Vineet & Patil, Darshana & Bahl, Ankur & Akolkar, Dadasaheb. (2023). Liquid and tissue profiling of targetable co-mutations with KRAS in non-small cell lung cancer.. Journal of Clinical Oncology. 41. e21201-e21201. 10.1200/JCO.2023.41.16_suppl.e21201.
  • Bahl, Ankur & Raizada, Niti & Dhar, Aparna & Agarwal, Amit & Bajaj, Rajat & Rohatgi, Nitesh. (2023). Does the landscape of comprehensive genomic profiling in patients with advanced stage lung cancer in India differ from data from the western countries.. Journal of Clinical Oncology. 41. e21011-e21011. 10.1200/JCO.2023.41.16_suppl.e21011.
  • Muddu, V. & Shah, A. & Raj, A. & Bahl, A. & Thirumalairaj, R. & Ghosh, Joydeep & Ostwal, Vikas & Rajappa, S. & Vora, A. & Lavingia, V. & Sharma, A. & Khan, A. & Rohatgi, Nitesh & Mahajan, M. & Chandrakanth, M. & Ramaswamy, Anant. (2023). P-209 Real-world study of durvalumab and chemotherapy in Indian patients with advanced biliary tract cancers. Annals of Oncology. 34. S90. 10.1016/j.annonc.2023.04.265.
  • Rohatgi, Nitesh & Limaye, Sewanti & Bahl, Ankur & Sirohi, Bhawna & Sahni, Sidharth & Patil, Darshana & Datta, Vineet & Limited, Datar & Crook, Tim & Kurzrock, Razelle & Cristofanilli, Massimo. (2023). Comprehensive molecular profiling from liquid and tissue for analysing the somatic mutational landscape in an Indian breast cancer cohort.. Journal of Clinical Oncology. 41. e13080-e13080. 10.1200/JCO.2023.41.16_suppl.e13080.
  • Vijayaraghavan, Pavitra & Kumar, Ganesh & Bahl, Ankur & Rohatgi, Nitesh. (2023). Is MET amplication an escape mechanism for even non-targetable mutations in lung cancer?. Lung Cancer. 178. S92. 10.1016/S0169-5002(23)00633-5.
  • Bahl, Ankur & Talwar, Vineet & Sirohi, Bhawna & Mehta, Prashant & Arya, Devavrat & Shrivastava, Gunjan & Dahiya, Akhil & Pavithran, Keechilat. (2020). Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC). Frontiers in Oncology. 10. 964. 10.3389/fonc.2020.00964.
  • Batra, Sandeep & Jha, Sanjeev & Bahl, Ankur & Chaturvedi, Harit & Taneja, Satyam. (2020). Outcome of FOLFOX based chemotherapy in advanced pancreatobiliary cancers presenting with hyperbilirubinemia.. Journal of Clinical Oncology. 38. e16605-e16605. 10.1200/JCO.2020.38.15_suppl.e16605.
  • Kulkarni, Padmaj & Gulia, Ashish & Bhosale, Bharat & K, Govind Babu & Raja, T & Bahl, Ankur & Talwar, Vineet & Vaid, Ashok. (2020). The growing menace of fake counterfeit and substandard medicines from across our borders.
  • Bahl, Ankur & Komal, & Pragati, & Mbbs, Choudhary & Singla, Suhas & Shrivastava, Gunjan & Bal, Jaspriya & Anand, Anil & Harit, & Ch, Chaturvedi & Bharat,. (2020). Palliative chemotherapy with or without Cetuximab in metastatic squamous cell carcinoma of head and neck: Indian tertiary care retrospective analysis. Head & Neck. 10.1002/hed.26070.
  • Mehta, Prashant & Talwar, Vineet & Bahl, Ankur. (2019). Leadership in immuno-oncology network 2 (LION:2) immunotherapy oncology - A present status. International Journal of Molecular and Immuno Oncology. 4. 2-5. 10.25259/IJMIO-2-2019.
  • M.Parikh, Purvish & Jhaveri, Karishma & Bahl, Ankur & Talwar, Vineet & Gandhi, Pritish & Singh, Randeep & Shreshta, Sudeep & Sahoo, TP. (2019). Special considerations for consent in immuno-oncology - Medic LAWgic recommendations. International Journal of Molecular and Immuno Oncology. 4. 6-8. 10.25259/IJMIO-3-2019.
  • Bahl, A & Choudhary, P & Bhatia, K & Singhla, S & Shrivastava, G & Bal, Jaspriya & Anand, Anil & Chaturvedi, H. (2018). 338PPalliative chemotherapy (CT) with or without cetuximab (CTX) in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): An Indian retrospective analysis. Annals of Oncology. 29. 10.1093/annonc/mdy438.031.
  • Bahl, A & Singh, R & Wadhwa, J & Gupta, S & Ahmed, Maleek & Uppal, PN & Parikh, PurvishM & Aggarwal, Shyam. (2018). Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer. South Asian Journal of Cancer. 7. 102. 10.4103/sajc.sajc_111_18.
  • K, Govind Babu & Bahl, Ankur & Bhattacharya, GS & Bhowmik, Kumar & Dattatraya, PS & Ghadyalpatil, Nikhil & Kulkarni, Padmaj & Sridharan, Nithya & Parikh, Purvish & Prabhash, Kumar & Raja, T & Rajasundaram, S & Subramanian, S & Talapatra, Kaustav & Vaid, Ashok. (2017). Oncology Gold Standard practical consensus recommendations for the use of monoclonal antibodies in the management of squamous cell carcinoma of head and neck. South Asian Journal of Cancer. 6. 154. 10.4103/sajc.sajc_181_17.
  • Verma, Amit & Rohatgi, Nitesh & Julka, Pramod & Walia, Meenu & Bahl, Ankur & Arora, Ramandeep & Chaturvedi, Harit & Anand, Anil & Rao, Ranga & Gay, Laurie & Kaur, Jatinder. (2017). FoundationOne as a relevant tool for comprehensive genomic profiling and assessment of tumor mutation burden in the era of precision oncology in India.. Journal of Clinical Oncology. 35. e23096-e23096. 10.1200/JCO.2017.35.15_suppl.e23096.
  • Solanki, Amrita & Rohatgi, Nitesh & Bahl, A & Haturvedi, H & Anand, A & Verma, A. (2016). INITIAL INDIAN EXPERIENCE WITH IMMUNOTHERAPY IN SOLID TUMORS. 10.13140/RG.2.2.31267.12329.
  • Biswas, Bivas & Sharma, Atul & Makharia, Govind & Thulkar, Sanjay & Arava, Sudheer & Bahl, Ankur & Chaudhary, Surendra. (2015). Immunoproliferative small intestinal disease: a report of 6 cases. Tropical gastroenterology : official journal of the Digestive Diseases Foundation. 35. 269-72.
  • Bahl, Ankur & Sharma, Atul & Raina, Vinod & Kumar, Lalit & Bakhshi, Sameer & Gupta, Ritu & Kumar, Rajeev. (2015). Long-term outcomes for patients with acute myeloid leukemia: A single-center experience from AIIMS, India: Long-term outcomes for patients with AML. Asia-Pacific journal of clinical oncology. 11. 10.1111/ajco.12333.
  • Bahl, Ankur & Kumar, Pankaj & Dar, Lalit & Mohanti, Bidhu & Sharma, Atul & Thakar, Alok & Karthikeyan, Venkat & Sikka, Kapil & Singh, Chiromamit & Poo, Kamala & Lodha, Jaini. (2014). Prevalence and trends of human papillomavirus in oropharyngeal cancer in a predominantly north Indian population. Head & neck. 36. 10.1002/hed.23317.
  • Bahl, Ankur & Bakhshi, Sameer. (2013). Umbilical Cord Blood Transplant for Malignancies: A Hope or Hype. Indian journal of pediatrics. 80. 10.1007/s12098-013-1046-3.
  • Kumar, Lalit & Cyriac, Sunu & Tvsvgk, Tilak & Bahl, Ankur & Biswas, Bivas & Sahoo, Ranjit & Mukherjee, Anjali & Sharma, Omdutt. (2012). Autologous Stem Cell Transplantation for Multiple Myeloma: Identification of Prognostic Factors. Clinical lymphoma, myeloma & leukemia. 13. 10.1016/j.clml.2012.08.007.
  • Sharma, Atul & Bahl, Ankur & Raina, Vinod & Kumar, Lalit & Gupta, Ritu. (2012). Dasatinib in chronic myeloid leukemia: A limited Indian experience. Asia-Pacific journal of clinical oncology. 8. 10.1111/j.1743-7563.2012.01557.x.
  • Bahl, Ankur & Dar, Lalit & Mohanti, Bidhu & Kumar, Pankaj & Thakar, Alok & Karthikeyan, Venkat & Sharma, Atul. (2012). Prevalence, trends, and survival impact of human papillomavirus on oropharyngeal cancer in Indian population.. Journal of Clinical Oncology. 30. 5540-5540. 10.1200/jco.2012.30.15_suppl.5540.
  • Bahl, Ankur & Bakhshi, Sameer. (2012). Metronomic Chemotherapy in Progressive Pediatric Malignancies: Old Drugs in New Package. Indian journal of pediatrics. 79. 10.1007/s12098-012-0759-z.
  • Bahl, A. & Mehta, Prashant & Raina, Vinod. (2012). Severe eosinophilia in metastatic carcinoma breast: A rare paraneoplastic phenomenon. European journal of Clinical and Medical Oncology. 4.
  • Bahl, Ankur & Bakhshi, Sameer. (2011). Dengue Fever in Patients With Pediatric Malignancy on Chemotherapy: A Concern in Tropical Countries. Pediatric blood & cancer. 57. 1249-50. 10.1002/pbc.23229.
  • A case of primary rectal non-Hodgkin's lymphoma treated with chemotherapy.Singla R, Kumar P, Bahl A, Kumar S, Saran RK, Kar P. Trop Gastroenterol. 2008 Oct- Dec;29(4):227-8.A case of primary rectal non-Hodgkin's lymphoma treated with chemotherapy.Singla R, Kumar P, Bahl A, Kumar S, Saran RK, Kar P. Trop Gastroenterol. 2008 Oct- Dec;29(4):227-8.
  • Acute onset flaccid quadriparesis in pediatric non-Hodgkin lymphoma: vincristine induced or Guillain-Barré syndrome? Bahl A, Chakrabarty B, Gulati S, Raju KN, Raja A, Bakhshi S. Pediatr Blood Cancer. 2010 Dec 1;55(6):1234-5.Acute onset flaccid quadriparesis in pediatric non-Hodgkin lymphoma: vincristine induced or Guillain-Barré syndrome? Bahl A, Chakrabarty B, Gulati S, Raju KN, Raja A, Bakhshi S. Pediatr Blood Cancer. 2010 Dec 1;55(6):1234-5.
  • Autologous Stem Cell Transplantation for Multiple Myeloma: Identification of Prognostic Factors. Kumar L, Cyriac SL, Tejomurtula TV, Bahl A, Biswas B, Sahoo RK, Mukherjee A, Sharma O. Clin Lymphoma Myeloma Leuk. 2012 Oct 18. pii: S2152-2650.Autologous Stem Cell Transplantation for Multiple Myeloma: Identification of Prognostic Factors. Kumar L, Cyriac SL, Tejomurtula TV, Bahl A, Biswas B, Sahoo RK, Mukherjee A, Sharma O. Clin Lymphoma Myeloma Leuk. 2012 Oct 18. pii: S2152-2650.
  • Carcinoma esophagus: a rare primary malignancy for ocular metastasis. Pal D, Bahl A, Sharma JB, Rao RR. Indian J Cancer. 2010 Oct-Dec;47(4):480-1.Carcinoma esophagus: a rare primary malignancy for ocular metastasis. Pal D, Bahl A, Sharma JB, Rao RR. Indian J Cancer. 2010 Oct-Dec;47(4):480-1.
  • Dasatinib in chronic myeloid leukemia: A limited Indian experience. Sharma A,Bahl A,Raina V,Kumar L,Gupta R. Asia Pac J Clin Oncol.2012 Jul 6.Dasatinib in chronic myeloid leukemia: A limited Indian experience. Sharma A,Bahl A,Raina V,Kumar L,Gupta R. Asia Pac J Clin Oncol.2012 Jul 6.
  • Dengue Fever in patients with pediatric malignancy on chemotherapy: a concern in tropical countries. Bahl A, Bakhshi S. Pediatr Blood Cancer. 2011 Dec 15;57(7):1249-50.Dengue Fever in patients with pediatric malignancy on chemotherapy: a concern in tropical countries. Bahl A, Bakhshi S. Pediatr Blood Cancer. 2011 Dec 15;57(7):1249-50.
  • Long-term outcomes for patients with acute myeloid leukemia: A single-center experience from AIIMS, India. Bahl A, Sharma A, Raina V, Kumar L, Bakhshi S, Gupta R, Kumar R. Asia Pac J Clin Oncol. 2015 Jan 30.Long-term outcomes for patients with acute myeloid leukemia: A single-center experience from AIIMS, India. Bahl A, Sharma A, Raina V, Kumar L, Bakhshi S, Gupta R, Kumar R. Asia Pac J Clin Oncol. 2015 Jan 30.
  • Metronomic Chemotherapy in Progressive Pediatric Malignancies: Old Drugs in New Package. Bahl A,Bakhshi S. Indian J Pediatr.2012 Apr 28.Metronomic Chemotherapy in Progressive Pediatric Malignancies: Old Drugs in New Package. Bahl A,Bakhshi S. Indian J Pediatr.2012 Apr 28.
  • Occipital condyle syndrome as a rare metastatic presentation of small cell lung carcinoma. Bahl A, Suresh P, Talwar V, Doval DC. Neurol India. 2010 Jul-Aug;58(4):666-8.Occipital condyle syndrome as a rare metastatic presentation of small cell lung carcinoma. Bahl A, Suresh P, Talwar V, Doval DC. Neurol India. 2010 Jul-Aug;58(4):666-8.
  • Prevalence and trends of human papillomavirus in oropharyngeal cancer in a predominantly north Indian population. Bahl A, Kumar P, Dar L, Mohanti BK, Sharma A, Thakar A, Karthikeyan V, Sikka K, Singh C, Poo K, Lodha J. Head Neck. 2014 Apr;36(4):505-10.Prevalence and trends of human papillomavirus in oropharyngeal cancer in a predominantly north Indian population. Bahl A, Kumar P, Dar L, Mohanti BK, Sharma A, Thakar A, Karthikeyan V, Sikka K, Singh C, Poo K, Lodha J. Head Neck. 2014 Apr;36(4):505-10.
  • Severe Eosinophilia in Metastatic Carcinoma Breast: A Rare Paraneoplastic Phenomenon. Ankur Bahl, Prashant Mehta, Vinod Raina. EJCMO 2011.Severe Eosinophilia in Metastatic Carcinoma Breast: A Rare Paraneoplastic Phenomenon. Ankur Bahl, Prashant Mehta, Vinod Raina. EJCMO 2011.
  • Synchronous carcinoma breast with chronic myelogenous leukemia: a rare presentation. Bahl A, Dhiman A, Talwar V, Doval DC. Indian J Cancer. 2010 Oct-Dec;47(4):477-9.Synchronous carcinoma breast with chronic myelogenous leukemia: a rare presentation. Bahl A, Dhiman A, Talwar V, Doval DC. Indian J Cancer. 2010 Oct-Dec;47(4):477-9.
  • Umbilical cord blood transplant for malignancies: a hope or hype. Bahl A, Bakhshi S. Indian J Pediatr. 2013 Aug;80(8):675-80

Frequently Asked Questions

Dr. Ankur Bahl is a leading medical oncologist at Fortis Memorial Research Institute, Gurugram.

To spread awareness about cancer and treatments.

No, appointments must be booked via Fortis Hospital.

He treats all solid and blood cancers.

Weight loss, lumps, bleeding, fatigue, etc.

Chemotherapy kills cells, immunotherapy boosts immunity, targeted therapy blocks signals.

No, many are curable especially when detected early.

It increases chances of successful treatment.

Avoid tobacco, eat healthy, exercise, limit alcohol.

It tells how far cancer has spread and guides treatment.

Yes, they help confirm diagnosis and explore options.

Yes, he offers support and care to international patients.
Send a Query